Karyopharm Therapeutics (KPTI) Finished Goods (2019 - 2025)
Karyopharm Therapeutics (KPTI) reported Finished Goods of $430000.0 for Q4 2025, down 9.85% on a YoY basis from $477000.0 in Q4 2024, and down 0.69% quarter-over-quarter from $433000.0 in Q3 2025.
Karyopharm Therapeutics (KPTI) Finished Goods (2019 - 2025) Analysis & Trends
Karyopharm Therapeutics has reported Finished Goods for 7 years, with the latest figure at $430000.0 in Q4 2025.
- For the quarter ending Q4 2025, Finished Goods fell 9.85% year-over-year to $430000.0; the trailing twelve-month figure through Dec 2025 stood at $430000.0 (down 9.85% YoY), and the FY2025 full-year result was $430000.0, down 9.85% from the prior year.
- Finished Goods for Q4 2025 stood at $430000.0, down from $433000.0 in the prior quarter.
- The five-year high for Finished Goods was $991000.0 in Q3 2022, with the low at $114000.0 in Q1 2021.
- Historically, Finished Goods has averaged $547600.0 across 5 years, with a median of $455000.0 in 2024.
- Annual changes were most pronounced in 2021 — Finished Goods jumped 424.05% — and 2025, when it slumped 44.02%.
- Karyopharm Therapeutics' Finished Goods stood at $414000.0 in 2021, then soared by 135.75% to $976000.0 in 2022, then declined by 22.34% to $758000.0 in 2023, then plunged by 37.07% to $477000.0 in 2024, then decreased by 9.85% to $430000.0 in 2025.
- The last three Finished Goods figures came in at $430000.0 (Q4 2025), $433000.0 (Q3 2025), and $349000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Karyopharm Therapeutics | 95.31 Mn | 31.56 Mn | 32.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 430,000.00 |
| Sep 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 349,000.00 |
| Mar 31, 2025 | 351,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | 542,000.00 |
| Jun 30, 2024 | 598,000.00 |
| Mar 31, 2024 | 627,000.00 |
| Dec 31, 2023 | 758,000.00 |
| Sep 30, 2023 | 759,000.00 |
| Jun 30, 2023 | 848,000.00 |
| Mar 31, 2023 | 936,000.00 |
| Dec 31, 2022 | 976,000.00 |
| Sep 30, 2022 | 991,000.00 |
| Jun 30, 2022 | 343,000.00 |
| Mar 31, 2022 | 385,000.00 |
| Dec 31, 2021 | 414,000.00 |
| Sep 30, 2021 | 398,000.00 |
| Jun 30, 2021 | 223,000.00 |
| Mar 31, 2021 | 114,000.00 |